The uptake and efflux of cyclic adenosine 3 ', by Escherichia coli membrane vesicles were studied. Metabolic energy was not required for the uptake process and was found to actually decrease the amount of 3',5'-cAMP found in the vesicles. 3',5'-cAMP uptake exhibits saturation kinetics (Km = 10 mM, V. = 2.8 nmol/mg of protein per min) and was competitively inhibited by a number of 3',5'-cAMP analogs. The uptake of 3',5'-cAMP was found to be sharply affected by a membrane phase transition. The excretion of 3',5'-cAMP was studied by using everted membrane vesicles. Efflux in this system was dependent upon metabolic energy and was reduced or abolished by uncouplers. Different energy sources powered efflux at different rates, showing a relationship between the degree of membrane energization and rate of excretion of 3',5'-cAMP. The efflux process also displayed saturation kinetics (Km = 10.0 mM, V.. = 0.98 nmol/mg of protein per mixi) and was competitively inhibited by the same 3',5'-cAMP analogs and to the same degree as was the uptake process. 3',5'-cAMP was found to be chemically unaltered by both the uptake and excretion processes. These data are interpreted as showing that the uptake and excretion of 3',5'-cAMP in E. coli membrane vesicles are carrier-mediated phenomena, possibly employing the same carrier system. Uptake is by facilitated diffusion whereas efflux is via an energy-dependent, active transport process. Evidence is presented showing that cells can regulate the number of 3',5'-cAMP transport carriers. The rate of 3',5'-cAMP excretion is possibly regulated by both the degree of membrane energization and the number of carriers present per cell.
3',5'-Cycic AMP (3',5'-cAMP) has been found to play an important regulatory role in many bacteria including Escherichia coli (19) . Many of the publications reporting these roles of 3',5'-cAMP were based on experiments in which 3',5'-cAMP was added to bacterial cultures, and the resulting effects were observed. An example of such an effect is the ability to exogenous 3',5'-cAMP to reverse glucose-caused catabolite repression of the lac operon.
In experiments described in early papers on the role of 3',5'-cAMP in regulation of inducible operons (8, 22) , the bacterial cells were pretreated with EDTA to render them more permeable before 3',5'-cAMP addition. This pretreatment was thought necessary because of the general impermeability of the E. coli membrane to nucleotides (9) . Perlman and Pastan later found, however, that exogenous 3',5'-cAMP caused the same effects in untreated cells (21) , thus obviatt Present address: Department of Microbiology, North Carolina State University, Raleigh, NC 27607. ing the need of subsequent researchers to use the EDTA treatment.
In view of the facts that many important data have been published based on experiments using exogenous 3',5'-cAMP and that nucleotides are generally considered incapable of being transported into the cell, it is unusual that little has been published concerning the uptake or transport of this nucleotide in bacteria. Publications to date show only that 3',5'cAMP can be excreted from bacterial cells (6, 15, 17, 23, 26, 30, 31) or offer indications that it can be taken up by certain membrane preparations (27) 
This report presents data which characterize the mechanism by which exogenous 3',5'-cAMP is transported across the cell membrane and also further characterizes the previously published 3',5'-cAMP efflux mechanism (26) . In addition, we present evidence indicating that the membrane transport of 3',5'-cAMP is regulated by the cell in at least two different ways.
Earlier attempts by this laboratory to study the transport of 3',5'-cAMP were made using whole cells of E. coli. Data from these experiments were enigmatic due to the apparent high amount of nonspecific binding of 3',5'-cAMP to cell wall material. For this reason, we used purified membrane vesicles, a technique well suited to investigating transport phenomena (22) .
MATERIALS AND METHODS Materials. 3',5'-cAMP, crystalline; 2',3'-cAMP, sodium salt; 2'-AMP; 5'-AMP, Sigma grade, crystalline; 3',5'-cGMP, sodium salt; adenosine, Sigma grade; Lascorbic acid; D-glucose-6-phosphate, monosodium salt, Sigma grade, crystalline; D-(-)-lactic acid, lithium salt; 2,4-dinitrophenol; lysozyme, grade I, from egg white; L-senne, Sigma grade; carbonyl cyanide m-chlorophenyl hydrazone; and phenazine methosulfate (PMS) were obtained from Sigma Chemical Co., St (10) . Upon completion of preparation, a sample was removed for protein determination and the remainder was divided into 1.0-ml portions, quick-frozen in liquid nitrogen, and then stored at -70°C until required. Preparations typically contained 3 to 4 mg of protein per ml. Everted vesicles were prepared from normally oriented vesicles which had been stored frozen at -70°C. After thawing, the normal vesicles (ca. 3 to 10 mg of protein)-were diluted to a total volume of 10.0 ml in cold 0.05 M KPO4 buffer (pH 7.0) and passed through a Aminco French pressure cell at 5,000 to 6,000 lb/in2. The everted vesicles were collected in a chilled, 30-ml glass centrifuge tube and sedimented at 20,000 x g for 30 mi. The pellet was gently resuspended in the same buffer to a volume equal to that which was thawed originally. Everted vesicles were used immediately for efflux experiments, for it was found that they lost transport activity if stored either cold or frozen at -70°C for more than several hours.
Serine and cAMP uptake assays. Each batch of vesicles prepared was tested for its ability to actively transport DL-['4C]serine. This was done following Kaback's procedure (10) and was conducted at 300C in the presence and absence of both 20 mM D-lactate and 0.4 mM 2,4-dinitrophenol. From such testing, it could be determined how much endogenous energy source was present in the vesicles and how actively the preparation could concentrate the amino acid. Calculations for determining intravesicular volume were taken from Lombardi and Kaback (13) . Only these vesicle preparations which could actively transport serine were used to study 3',5'-cAMP transport. The uptake of 3',5'-[3H]cAMP was tested using Kaback's amino acid transport assay method (10) . Volumes were increased proportionally to allow the use of 0.1 or 0.2 ml of vesicles (300 to 800 ,tg of protein) per assay tube. All data presented represent the average of three to five identical assays, and all experiments were repeated an average of three to five times to assure validity of results. Uptake could only be observed accurately if 3 50 and 10°C depending on the temperature of the water bath or the presence of salt in the ice water. For use, uptake assay tubes (12 by 75 mm) were inserted into the water-filled holes and allowed to equilibrate, and the reaction was begun. Termination and filtration were the same as in other assays. Identification of uptake product. Vesicles containing 0.915 mg of protein were allowed to take up 0.8 mM 3'5'-[3H]cAMP for 20 min in a normal uptake assay procedure. Uptake was terminated, the vesicles were filtered, and 3',5'-cAMP was extracted as described elsewhere (26) . The extract was spotted (50 1d) on a cellulose thin-layer chromatography plate Identification of efflux product. The compound taken up by everted vesicles was identified by cochromatography as described above but with the following changes. Everted vesicles (2.66 mg of protein) were used and allowed to take up 2.0 mM 3'5'-[3H]-cAMP (6.66 x 106 cpm/,umol) for 10 min using 50 mM ascorbate and 0.1 mM PMS as an energy source. In another experiment, everted vesicles were heat killed by 10 min of boiling before being used as above. After 10 min of uptake, the vesicles were filtered and washed, and the intravesicular material was extracted. cAMP. The dilution mixture was at the same temperature as the uptake mixture. After dilution, 2.0-ml samples of the vesicles were removed at appropriate times, filtered, washed, and counted as described previously.
Measurement of radioactivity. Samples were counted on a Nuclear-Chicago Mark IV liquid scintillation counter, using either toluene or Triton-based scintillation fluid as described elsewhere (7).
Protein determination. Membrane vesicles were digested in 0.1 N NaOH, and their protein content was determined by the Folin method (14) , using bovine serum albumin as a standard.
Kinetic analysis of uptake. The Km and V, of uptake were determined graphically using Lineweaver-Burk plots (12) . Ki values were derived by the procedure of Neame and Richards (18) .
RESULTS
Uptake of 3',5'-[3H]cAMP with time. The uptake of 3',5'-cAMP by membrane vesicles was linear with respect to time for at least 6 miin and then reached a plateau after 10 min. All subsequent uptake studies were performed for time periods of less than 6 min, so that initial velocity rates were measured. The internal concentration of 3',5'-cAMP in the vesicles after 10 min of uptake was calculated to be 0.96 mM, which was 96% of the external level of added 3',5'-cAMP. Vesicles which were heat killed by 10 min of boiling before use showed essentially no uptake of 3',5'-cAMP as a function of time.
Role of cellular energy in 3',5'-[3H]cAMP uptake. When the artificial electron donor system of ascorbate-PMS was added to the uptake assay mixture, a 26% reduction in the amount of 3',5'-cAMP taken up was observed (Fig. 1 figure. effects of temperature and a membrane phase transition on 3',5'-[3H]cAMP uptake were determined (Fig. 3) cles. 3',5'-[3H]cAMP levels added varied from 2 to 14 mM, and uptake was powered by ascorbate-PMS. Analysis of a double-reciprocal plot (Fig. 4, insert) figure. about 2.5-fold more rapidly than the vesicles prepared from the control culture (glucose vesicles). Values shown in Fig. 5 represent initial velocity rates within the first-order kinetics portion ofthe Michaelis-Menten plot and are, therefore, easily compared. Similar findings were made in another experiment, in which uptake was tested over a wider range of substrate concentrations (Fig. 6) . Substrate concentrations greater than 5 mM fall out of the range of firstorder kinetics and, therefore, a double-reciprocal plot can be made (Fig. 6B) . Results show that uptake of 3',5'-cAMP in both 3',5'-cAMP vesicles and glucose vesicles displays the same Ki, but the Vmax of the uptake in 3',5'-cAMP vesicles is the greater of the two. These data can be interpreted as showing that the 3',5'-cAMP vesicles contained a greater number of 3',5'-cAMP carrier molecules, each having similar Km values, or binding affinity for the transport substrate.
It has been shown by others that E. coli strains which lack a functional cytoplasmic 3',5'-cAMP receptor protein produce and excrete larger amounts of 3',5'-cAMP than do wild-type strains (24, 25, 31) . For this reason, we tested the uptake of 3',5'-cAMP in vesicles made from such a mutant (C51, crp) which was grown on glucose and in the absence of added 3',5'-cAMP. It was found (Fig. 5 ) that these vesicles displayed 3',5'-cAMP uptake traits almost identical to those of 3',5'-cAMP vesicles prepared from the wild-type strain. Both could take up approximately 2.5 times more 3',5'-cAMP in the 2-min assay period than the control, wild-type glucose vesicles. vesicles by means of a carrier-mediated, energyindependent transport mechanism. Data supporting the conclusion that the uptake process does not require an energized membrane ( Fig. 1 (5, 28) . The uptake of 3',5'-cAMP by membrane vesicles conforms to all three of these criteria and, therefore, is probably carrier mediated.
The rather high Km for 3',5'-cAMP uptake and the use of metabolic energy for effiux but not uptake can explain why high concentrations of exogenous 3',5'-cAMP are required to produce effects brought about by lower endogenous levels of this nucleotide. The high Km value also raises questions concerning the true function of the 3',5'-cAMP carrier system. The carrier could function primarily in the transport of substrates other than 3',5'-cAMP, such as nucleosides or purine bases. Alternatively, the carrier could function primarily in the excretion of 3',5'-cAMP from the cell, and its role in 3',5'-cAMP uptake is an artifactual one, created by the presence of high exogenous levels of 3',5'-cAMP not naturally encountered by E. coli.
Saier and his co-workers have shown that the effiux of 3',5'-cAMP from both whole celLs and membrane vesicles of E. coli is an active transport process which is powered by energy sources similar to those known to energize amino acid uptake (26) . In addition, they showed that the active efflux from preloaded vesicles was best powered by ascorbate-PMS, and that D-lactate, although more efficient than succinate, was not as good an energy source as the ascorbate-PMS. Our results, based on both uptake by everted vesicles and effiux from normal, preloaded vesicles, are in agreement with those of Saier's laboratory.
Other data in our report serve to further elucidate the 3',5'-cAMP active efflux process. The observations that efflux follows saturation kinetics and is capable of competitive inhibition by substrate analogs provide evidence for the involvement of a carrier in the transport process. The identification of the efflux product as being 3',5'-cAMP shows that the nucleotide is excreted in a chemically unaltered form and, therefore, rules out group translocation as a transport mechanism.
It is of interest to note that the Km for efflux is 10 mM, showing that the carrier will function at maximal velocity only when extremely high concentrations of 3',5'-cAMP are present in the cell. The carrier is thus also saturated when the 3',5'-cAMP levels are quite high. These obser- (26) .
We wish to hypothesize that the uptake and excretion of 3',5'-cAMP by E. coli membranes is mediated by a common type of carrier system. Data presented indicate that both processes are saturated by the same levels of 3',5'-cAMP and also show that transport of this substrate in both directions across the membrane is inhibited to the same relative degree by a number of substrate analogs. In addition, theoretical consideration can be used to argue for the existence of a common carrier. To effectively alter the metabolism of E. coli, exogenous levels of 3',5'-cAMP must usually be in the range of from 1 to 5 mM. It is highly doubtful if 3',5'-cAMP concentrations of this order are ever found in this organism's native habitat. Also, if the uptake carrier had evolved as a system separate from the efflux carrier, it seems unlikely that it would function with such inefficiency as is caused by its high Km and lack of energy coupling.
We further propose that the activity of individual carriers is not actively regulated (as stated by Epstein [6] ) but that E. coli can, instead, control 3',5'-cAMP transport primarily by varying the number of carriers found in each cell. Data supporting this conclusion are seen in Fig.  5 and 6. Kinetic analysis (Fig. 6 ) of 3',5'-cAMP uptake in vesicles prepared from cells grown in both the presence and absence of 1.25 mM 3',5'-cAMP shows that the Km of uptake was the same in both cases. The Vn,,, of uptake in the 3',5'-cAMP vesicles, however, was almost 2.5 times greater than the Vm.x value of vesicles prepared from cells grown in the absence of 3',5'-cAMP. In another series of experiments (Fig. 5) , the initial velocity of uptake was compared in vesicles also prepared from cells grown in both the presence and absence of added 1.25 mM 3',5'-cAMP. Similar results were obtained, for the 3',5'-cAMP vesicles showed initial velocity rates approximately threefold greater than the control vesicles. As described in Results, uptake of 3',5'-cAMP in vesicles made from strain C51 (crp) was tested, and the initial velocity of uptake in these vesicles was similar to that in the 3',5'-cAMP vesicles prepared from the wild-type strain (Fig.  5) . Since crp strains have been shown to contain and excrete higher amounts of 3',5'-cAMP than wild-type strains, these cultures were then grown under conditions similar to wild-type cells to which exogenous 3',5'-cAMP was added. In both cases, the intracellular level of the nucleotide is elevated above normal amounts. From these data, it can be hypothesized that, in an attempt to lower such abnornally high intracellular concentrations of 3',5'-cAMP, E. coli synthesizes a larger number of 3',5'-cAMP transport carriers. Such a condition would be reflected by an increase in the Vmax and an unaltered Km value for transport.
In summary, we have presented evidence that the level of intracellular 3',5'-cAMP in E. coli can be regulated in part by controlling the number of 3',5'-cAMP transport carriers per cell and by the degree of energization of the cytoplasmic membrane. When high levels of exogenous 3',5'-cAMP are added to cultures of E. coli, the final intracellular level of this nucleotide would represent a level determined by the rates of simnultaneous uptake and efflux. Since excretion seems to be more efficient than uptake, the final intracellular level will not reach that of the extemal concentration of added 3',5'-cAMP. Both the uptake and efflux of 3',5'-cAMP are probably mediated by the same carrier system. Uptake is a facilitated diffusion process, whereas the efflux of 3',5'-cAMP is an active transport reaction.
